statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	752
SG - Singapore	167
CN - Cina	100
GB - Regno Unito	75
SE - Svezia	64
HK - Hong Kong	60
DE - Germania	52
BR - Brasile	49
IT - Italia	38
FI - Finlandia	34
RU - Federazione Russa	29
VN - Vietnam	25
FR - Francia	20
CA - Canada	15
ID - Indonesia	8
BG - Bulgaria	6
IN - India	6
MX - Messico	6
PL - Polonia	6
SI - Slovenia	6
ZA - Sudafrica	6
AR - Argentina	5
AT - Austria	5
MY - Malesia	5
JP - Giappone	4
MA - Marocco	4
TR - Turchia	4
UA - Ucraina	4
KR - Corea	3
LT - Lituania	3
NL - Olanda	3
AE - Emirati Arabi Uniti	2
IR - Iran	2
NZ - Nuova Zelanda	2
PY - Paraguay	2
UZ - Uzbekistan	2
AD - Andorra	1
AG - Antigua e Barbuda	1
BD - Bangladesh	1
BE - Belgio	1
BF - Burkina Faso	1
CL - Cile	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
ES - Italia	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
LA - Repubblica Popolare Democratica del Laos	1
NP - Nepal	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
PK - Pakistan	1
TW - Taiwan	1
VE - Venezuela	1
ZM - Zambia	1
Totale	1.597

Nome	#
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study	244
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison	236
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART	218
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study	164
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients	164
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort	162
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy	154
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART	134
Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe	131
Totale	1.607

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	104	0	0	0	0	0	46	6	14	12	6	16	4
2021/2022	109	1	9	8	2	5	2	3	7	18	4	24	26
2022/2023	241	38	34	23	15	34	17	7	26	14	0	11	22
2023/2024	128	4	10	12	15	29	10	13	17	1	3	5	9
2024/2025	467	14	7	4	42	75	69	44	22	63	18	36	73
2025/2026	431	63	36	46	98	155	33	0	0	0	0	0	0
Totale													1.607